SCOPUS 정보 검색 플랫폼

American Journal of Health-System Pharmacy

Volumn 59, Issue SUPPL., 2002, Pages

Novel approaches to anemia associated with cancer and chemotherapy

(1) Kolesar, Jill M a

a UNIVERSITY OF WISCONSIN MADISON (United States)

Author keywords

Anemia; Antianemia drugs; Antineoplastic agents; Darbepoetin alfa; Epoetin alfa; Half life; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; DRUG DERIVATIVE; ERYTHROPOIETIN;

ANEMIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONFERENCE PAPER; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; ERYTHROPOIESIS; HEMOGLOBIN DETERMINATION; HUMAN; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; TRANSFUSION; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; HALF LIFE TIME; REVIEW;

ANEMIA; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; EPOETIN ALFA; ERYTHROPOIETIN; HALF-LIFE; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 0036683777 PISSN: 10792082 EISSN: None Source Type: Journal
DOI: 10.1093/ajhp/59.suppl_4.s8 Document Type: Conference Paper

Times cited : (7)

References (18)

1
- 0034278967
- Sorting out the common anemias
- (2000) J Am Acad Physician Assist , vol.1 , Issue.9 , pp. 39-49
- Onega, T.¹

2
- 0034994238
- Fatigue: A main component of anemia symptomatology
- (2001) Semin Oncol , vol.28 , Issue.2 SUPPL. 8 , pp. 15-18
- Sobrero, A.¹ Puglisi, F.² Guglielmi, A.³

3
- 0034997122
- Anaemia and its functional consequences in cancer patients: Current challenges in management and prospects for improving therapy
- (2001) Br J Cancer , vol.84 , Issue.SUPPL. 1 , pp. 31-37
- Demetri, G.D.¹

4
- 0034993236
- Symptomatology of anemia
- (2001) Semin Oncol , vol.28 , Issue.2 SUPPL. 8 , pp. 7-14
- Ludwig, H.¹ Strasser, K.²

5
- 0034994237
- Biological basis of anemia
- (2001) Semin Oncol , vol.28 , Issue.2 SUPPL. 8 , pp. 1-6
- Bron, D.¹ Meuleman, N.² Mascaux, C.³

6
- 0034827135
- Anemia of cancer: An overview
- (2001) Tumori , vol.87 , Issue.2
- Cantoni, S.¹ Morra, E.²

7
- 0033791567
- Overview: Erythropoiesis, anemia, and the impact of erythropoietin
- (2000) Semin Hematol , vol.37 , Issue.4 SUPPL. 6 , pp. 1-3
- Gabrilove, J.¹

8
- 0031044609
- Impact of therapy with epoetin alpha on clinical outcomes in patients with non-myeloid malignancies during cancer chemotherapy in community oncology practice
- (1997) J Clin Oncol , vol.15 , pp. 1218-1234
- Glaspy, J.¹ Bukowski, R.² Steinberg, D.³

9
- 0031785826
- Quality of life benefit in chemotherapy patients treated with epoetin alpha is independent of disease response or tumor type: Results from a prospective community oncology study
- (1998) J Clin Oncol , vol.16 , pp. 3412-3425
- Demetri, G.D.¹ Kris, M.² Wade, J.³

10
- 0035366382
- Once weekly dosing of epoetin is similar to three times a week dosing in increasing hemoglobin and quality of life
- (2001) J Clin Oncol , vol.19 , pp. 2875-2882
- Gabrilove, J.L.¹ Einhorn, L.H.² Livingston, R.B.³

11
- 0035503198
- Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy
- (2001) J Clin Oncol , vol.19 , pp. 4126-4134
- Quirt, I.¹ Robeson, C.² Lan, C.Y.³

12
- 0035021354
- A dose finding study of novel erythropoiesis stimulating protein (NESP) for the treatment of anemia in patients receiving multi-cycle chemotherapy
- (2001) Br J Cancer , vol.84 , pp. 17-23
- Glaspy, J.¹ Jadeja, J.S.² Justice, G.³

13
- 0034959059
- An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)
- (2001) Nephrol Dial Transplant , vol.16 , Issue.SUPPL. 3 , pp. 14-21
- Macdougall, I.C.¹

14
- 0000367668
- Randomized double-blind placebo controlled Phase I/II dose finding study of Aranesp administered every three weeks in solid tumor patients
- Abstract
- (2000) Proc Am Soc Hem , pp. 1268
- Kotasek, D.¹ Berg, R.² Poulsen, A.³

15
- 0035000303
- Novel erythropoiesis stimulating protein (NESP) for the treatment of anemia of chronic disease associated with cancer
- (2001) Br J Cancer , vol.84 , pp. 24-30
- Smith, R.E.¹ Jaiyesimi, I.A.² Meza, L.A.³

16
- 0000679267
- A randomized, blinded, placebo controlled Phase II, dose finding study of novel erythropoiesis stimulating protein (NESP) in patients with lymphoproliferative malignancies
- (2001) Proc Am Soc Clin Oncol , vol.20 , pp. 1569
- Hedenus, M.¹ Hansen, S.² Dewey, C.³

17
- 0002270247
- Darbepoetin alfa administered every 1 or 2 weeks (with no loss of dose efficiency) alleviates anemia inpatients with solid tumors
- Abstract
- (2002) Proc Euro Hem Assoc , vol.3 , pp. 67
- Glaspy, J.¹ Jadeja, J.² Justice, G.³

18
- 0001329332
- A Phase III, double-blind, placebo controlled randomized study of novel erythropoiesis stimulating protein (NESP) in patients undergoing platinum treatment for lung cancer
- Abstract
- (2001) Proc ASCO , vol.20 , pp. 394
- Pirker, R.¹ Vansteenkiste, J.² Gately, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.